Search

everythinglearnresearchcommunity

for

Search:↓

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

PRP therapy safely improves hair growth in people with hair loss.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Various treatments exist for hair loss, but more research is needed for better options.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

Storing hair follicle micrografts for longer times can cause them to enter a state similar to the natural hair shedding phase, which might impact hair transplant results.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

All-trans retinoic acid at high doses harms goat hair growth cells and could be bad for hair growth.

Thymosin β4 helps increase hair growth in Cashmere goats.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Using microneedling with PRP improves skin and hair conditions more than microneedling alone.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Better hair loss models needed for research.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Some extracts from woods and fungi can promote hair growth better than a known hair growth substance.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.

Modifying certain signals in the body can help wounds heal without scars and regrow hair.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.